S&T Bank Abbott Laboratories Transaction History

S&T Bank

$381 Million
Q3 2024

A detailed history of S&T Bank transactions in Abbott Laboratories stock. As of the latest transaction made, S&T Bank holds 10,408 shares of ABT stock, worth $1.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

10,408

Previous 18,128 42.59%

Holding current value

$1.2 Million

Previous $1.88 Million 37.0%

% of portfolio

0.31%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $772,540 - $911,963	-7,720 Reduced 42.59%	10,408 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $90,959 - $101,533	-903 Reduced 4.74%	18,128 $1.88 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $171,946 - $189,907	-1,570 Reduced 7.62%	19,031 $2.16 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $79,006 - $96,710	-876 Reduced 4.08%	20,601 $2.27 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $38,689 - $46,421	405 Added 1.92%	21,477 $2.08 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $16,527 - $18,415	-164 Reduced 0.77%	21,072 $2.3 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $120,009 - $141,258	-1,239 Reduced 5.51%	21,236 $2.15 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $208,656 - $244,786	-2,195 Reduced 8.9%	22,475 $2.47 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $315,050 - $364,769	-3,256 Reduced 11.66%	24,670 $2.39 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $3,266 - $3,947	32 Added 0.11%	27,926 $3.03 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $56,895 - $69,380	499 Added 1.82%	27,894 $3.3 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $35,121 - $43,003	304 Added 1.12%	27,395 $3.86 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $902,948 - $998,924	7,740 Added 40.0%	27,091 $3.2 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $182,910 - $215,312	1,729 Added 9.81%	19,351 $2.24 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $38,964 - $45,906	-358 Reduced 1.99%	17,622 $2.11 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $589,050 - $641,896	5,610 Added 45.35%	17,980 $1.97 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $29,233 - $35,501	-319 Reduced 2.51%	12,370 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $55,053 - $70,462	719 Added 6.01%	12,689 $1.16 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $193,422 - $282,836	-3,079 Reduced 20.46%	11,970 $945,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $128,442 - $142,986	-1,636 Reduced 9.81%	15,049 $1.31 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $172,109 - $186,620	-2,103 Reduced 11.19%	16,685 $1.4 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $9,838 - $11,475	135 Added 0.72%	18,788 $1.58 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $35,030 - $42,351	-529 Reduced 2.76%	18,653 $1.49 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $12,456 - $14,111	190 Added 1.0%	19,182 $1.39 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $11,797 - $14,231	-194 Reduced 1.01%	18,992 $1.39 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $50,661 - $55,915	880 Added 4.81%	19,186 $1.17 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $1.03 Million - $1.16 Million	18,306 New	18,306 $1.1 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $3.39 Million - $3.63 Million	-63,138 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $99,820 - $111,410	-2,077 Reduced 3.18%	63,138 $3.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,215	65,215 $3.17 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.

Account